XtalPi Holdings Limited (SEHK: 2228)
Health Care · Life Sciences Tools & Services · CN
HK$6.99
-12.08% today · -37.9% 1Y
XtalPi Holdings Limited (SEHK: 2228) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $3.83B and employs 1,254 people.
Over the last twelve months the share price has lost 37.9%, trading between 6.30 and 14.28.
Tweenvest scores XtalPi Holdings Limited across four factors: quality 42/100, value 72/100. Its strongest factor is value.
2228 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.83B
- Revenue (TTM)
- $99.98M
- P/E
- —
- EPS
- -0.05
- Dividend yield
- —
- Beta (5Y)
- 1.17
- 52-week high
- HK$14.28
- 52-week low
- HK$6.30
- Avg volume (3M)
- —
- Shares outstanding
- 4.30B
- Employees
- 1,254
- Next earnings
- —
About XtalPi Holdings Limited
XtalPi Holdings Limited functions as an investment holding company, delivering sophisticated drug discovery and intelligent automation solutions across key markets including China, the United States, Europe, South Korea, and Japan. Its comprehensive drug discovery services encompass the entire research and development process, ranging from target validation and hit identification to lead generation, lead optimization, and PCC nomination. These services are adept across diverse therapeutic modalities, such as small molecules, antibodies, peptides, ADCs, and PROTACs. The company's intelligent automation solutions specifically utilize artificial intelligence and automation to facilitate the accelerated discovery and research of novel drugs and materials. Established in 2015 and based in Shenzhen, China, the firm was formerly known as QuantumPharm Inc. before officially changing its name to XtalPi Holdings Limited in December 2024.
- ISIN
- KYG7S12M1051
- Founded
- 2015
- Listed since
- Jun 13, 2024
- Exchange
- The Stock Exchange of Hong Kong Ltd.
- Currency
- HKD
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Adaptive Biotechnologies CorporationNasdaqGS: ADPT | $4.23B | $25.43 | -4.00% |
| MGI Tech Co., Ltd.SHSE: 688114 | $4.18B | CN¥67.95 | -5.49% |
| AbCellera Biologics Inc.NasdaqGS: ABCL | $4.07B | $12.89 | +2.71% |
| SCHOTT Pharma AG & Co. KGaAXTRA: 1SXP | $3.96B | €24.10 | +2.55% |
| InSilico Medicine Cayman TopCoSEHK: 3696 | $3.60B | HK$49.00 | +1.58% |
| Siegfried Holding AGSWX: SFZN | $3.56B | CHF68.10 | +0.89% |
| Tecan Group AGSWX: TECN | $3.49B | CHF236.80 | +0.77% |
| Sai Life Sciences LimitedNSEI: SAILIFE | $3.27B | Rs1,487.90 | -3.46% |
Figures last refreshed Oct 11, 2026.